Document is current

Any future updates will be listed below

KEYNOTE-811: pembrolizumab in advanced HER2+ gastric cancer

Crossref DOI link: https://doi.org/10.1038/s41575-022-00577-y

Published Online: 2022-01-11

Published Print: 2022-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark